Sunday, June 24 , 2018, 11:37 pm | Overcast 63º

 
 
 
 

Researchers at UCSB Weimbs Lab Show Reduced Food Intake Diminishes Polycystic Kidney Growth in Mice

Thomas Weimbs

What if polycystic kidney disease (PKD) could be combated with a strategy as simple as dieting? Such a finding would surely be welcome news to the 12 million people worldwide with the genetic disease.

New research from UC Santa Barbara suggests that reducing food intake may slow the growth of the cysts that are symptomatic of PKD, an inherited disorder in which clusters of cysts develop in the kidneys.

A study by biologist Thomas Weimbs and colleagues has demonstrated that in mouse models, a modest decrease in food intake resulted in substantially diminished cyst growth. The findings appear in the American Journal of Physiology - Renal Physiology.

“Amazingly, the growth of polycystic kidneys was quite strongly inhibited with the reduced food intake, suggesting that these organs are much more sensitive to nutrients than the rest of the body,” said Weimbs, a professor in UCSB’s Department of Molecular, Cellular, and Developmental Biology. “That’s very interesting because if we translate this to a human population, the regimen should be something that would be potentially feasible for PKD patients to follow.”

The researchers were particularly interested in the mTOR pathway, the mechanistic target of a drug called rapamycin, which has been studied as a potential treatment for PKD.

When nutrients are abundant, the mTOR pathway — important in regulating cell growth and proliferation — is highly active.

The investigators hypothesized that limiting nutrient supply might affect the pathway’s activity and tested their theory in mice with polycystic kidneys.

Animals in the control group had free access to food and showed a kidney weight increase of 151 percent during the study period. Those in the experimental group, in which food intake was reduced 23 percent, experienced only a 41 percent gain in kidney weight.

“That’s pretty substantial,” said Weimbs. “The reduction is similar to what we would see with rapamycin treatment but without the side effects.”

The researchers also looked at other parameters, such as proliferation of the cysts and the inhibition of other molecular pathways.

“Not only did the size of cysts decrease significantly but pathways were inhibited as we expected them to be,” Weimbs said. “All of this made sense with our initial hypothesis.”

Moving from animal to human studies, however, would require additional research as well as clinical trials. Still to be determined is whether the sizable effects seen in this study are due to simply decreasing caloric intake or to a reduction in a particular nutrient group, such as carbohydrates, lipids or proteins.

“That’s something we really don’t know, but it’s something that can be easily tested and should be, because potentially we only have to reduce one nutrient group and not all of the others,” Weimbs explained. “Or maybe it’s just the caloric intake. We need to know which before it makes sense to move forward with a clinical trial.”

The results of the Weimbs Lab’s research are similar to another recent study conducted at the Mayo Clinic in Rochester, Minn. While that group used slightly different mouse models and a more severe level of food restriction — 40 percent — the results also demonstrated a reduction in cyst growth.

“Two groups using different protocols and different models that come to the same conclusion strengthens the overall findings and makes a clinical trial much more justifiable,” Weimbs concluded.

Julie Cohen writes for the UCSB Office of Public Affairs and Communications.

 

Support Noozhawk Today

You are an important ally in our mission to deliver clear, objective, high-quality professional news reporting for Santa Barbara, Goleta and the rest of Santa Barbara County. Join the Hawks Club today to help keep Noozhawk soaring.

We offer four membership levels: $5 a month, $10 a month, $25 a month or $1 a week. Payments can be made through PayPal below, or click here for information on recurring credit-card payments.

Thank you for your vital support.

Become a Noozhawk Supporter

First name
Last name
Enter your email
Select your membership level
×

Payment Information

You are purchasing:

Payment Method

Pay by Credit Card:

Mastercard, Visa, American Express, Discover

Pay with Apple Pay or Google Pay:

Noozhawk partners with Stripe to provide secure invoicing and payments processing.

  • Ask
  • Vote
  • Investigate
  • Answer

Noozhawk Asks: What’s Your Question?

Welcome to Noozhawk Asks, a new feature in which you ask the questions, you help decide what Noozhawk investigates, and you work with us to find the answers.

Here’s how it works: You share your questions with us in the nearby box. In some cases, we may work with you to find the answers. In others, we may ask you to vote on your top choices to help us narrow the scope. And we’ll be regularly asking you for your feedback on a specific issue or topic.

We also expect to work together with the reader who asked the winning questions to find the answer together. Noozhawk’s objective is to come at questions from a place of curiosity and openness, and we believe a transparent collaboration is the key to achieve it.

The results of our investigation will be published here in this Noozhawk Asks section. Once or twice a month, we plan to do a review of what was asked and answered.

Thanks for asking!

Click Here to Get Started >

Reader Comments

Noozhawk is no longer accepting reader comments on our articles. Click here for the announcement. Readers are instead invited to submit letters to the editor by emailing them to [email protected]. Please provide your full name and community, as well as contact information for verification purposes only.

Daily Noozhawk

Subscribe to Noozhawk's A.M. Report, our free e-Bulletin sent out every day at 4:15 a.m. with Noozhawk's top stories, hand-picked by the editors.

Sign Up Now >